multipl
sclerosi
ms
common
chronic
inflammatori
diseas
nervou
system
diseas
exclus
involv
central
nervou
system
cn
associ
disord
ms
affect
white
popul
lead
time
sever
disabl
half
ms
occur
twice
often
women
men
usual
start
age
year
major
patient
diseas
cours
character
onset
remiss
neurolog
symptom
origin
differ
area
cn
relaps
remit
rrm
time
number
relaps
decreas
patient
develop
progress
neurolog
deficit
occur
independ
acut
bout
secondari
progress
ms
spm
produc
signific
disabl
patient
diseas
run
primari
progress
pp
cours
onset
without
superimpos
relaps
spm
ppm
share
sever
clinic
featur
includ
similar
extent
speed
progress
differ
rrm
form
progress
ms
also
evid
magnet
reson
imag
mri
brain
spinal
cord
patient
rrm
acut
cn
lesion
follow
spontan
resolut
frequent
observ
even
clinic
silent
period
lesion
mostli
locat
white
matter
often
character
disturb
bloodbrain
barrier
local
edema
demyelin
reflect
acut
inflamm
evolv
sp
phase
patient
ppm
inflammatori
chang
less
pronounc
global
atrophi
develop
seem
correl
disabl
find
suggest
exist
two
distinct
diseas
phase
ms
initi
stage
rrm
character
recurr
episod
acut
cn
inflamm
focus
white
matter
progress
stage
character
predomin
neurodegener
decreas
inflamm
second
phase
may
preced
inflammatori
phase
may
also
unfold
independ
ppm
genet
environment
factor
influenc
suscept
cours
ms
preval
ms
vari
strongli
depend
genet
background
preval
high
white
ms
rare
asian
african
famili
member
ms
patient
greater
risk
rang
higher
monozygot
twin
higher
children
ms
patient
contrast
preval
spous
adopt
children
increas
multipl
genom
screen
famili
studi
recent
complet
indic
ms
follow
polygenet
trait
involv
larg
number
gene
contribut
littl
overal
risk
furthermor
studi
also
provid
evid
signific
heterogen
suscept
gene
role
genet
factor
even
complex
appear
also
impact
diseas
cours
result
polygenet
heterogen
genet
predisposit
posit
clone
candid
gene
approach
larg
unsuccess
yield
inconclus
result
human
leukocyt
antigen
hla
class
ii
allel
consist
associ
ms
white
rel
risk
although
associ
establish
year
ago
still
unknown
hla
allel
confer
greater
suscept
contract
ms
multipl
sclerosi
ms
chronic
inflammatori
demyelin
diseas
central
nervou
system
although
immun
system
seem
play
import
role
pathogenesi
diseas
target
antigen
still
uncertain
pathway
lead
tissu
destruct
fulli
elucid
recent
studi
significantli
contribut
better
understand
diseas
process
broaden
view
possibl
scenario
diseas
initi
progress
review
role
immun
system
manifest
evolut
ms
discuss
differ
pathogenet
concept
conclud
outlook
futur
strategi
identifi
caus
ms
besid
genet
influenc
epidemiolog
migrat
studi
provid
circumstanti
evid
environment
possibl
transmiss
factor
pathogenesi
ms
relaps
associ
common
viral
infect
risk
develop
ms
highest
area
moder
climat
migrat
highrisk
lowrisk
area
adolesc
reduc
risk
develop
ms
wherea
migrat
lowrisk
highrisk
area
increas
risk
develop
ms
impact
environment
factor
also
underlin
ms
epidem
one
faro
island
island
ms
unknown
british
soldier
land
within
year
high
incid
ms
case
observ
sinc
diseas
occur
regular
basi
faro
island
multipl
sclerosi
diseas
predominantli
although
exclus
affect
cn
white
matter
lead
demyelin
lesion
lesion
locat
around
ventricl
relat
small
vessel
acut
ms
lesion
demyelin
axon
activ
microglia
infiltr
immun
cell
key
featur
infiltr
mostli
consist
cell
macrophag
b
cell
plasma
cell
also
found
lower
number
extens
antibodi
deposit
seen
part
patient
eosinophil
granulocyt
sometim
encount
immun
cell
granulocyt
cell
natur
killer
cell
larg
absent
lesion
among
cell
cell
outnumb
cell
parenchyma
wherea
later
one
found
frequent
cuff
mening
array
differ
lymphokin
chemokin
proteas
express
acut
ms
lesion
work
perform
lucchinetti
et
al
suggest
acut
demyelin
lesion
significantli
differ
term
oligodendrocyt
patholog
presenc
absenc
inflammatori
demyelin
chang
extent
remyelin
two
pattern
note
frequent
one
character
signific
antibodi
deposit
remyelin
oligodendrocyt
loss
without
remyelin
high
degre
heterogen
also
demonstr
cerebrospin
fluid
csf
cytolog
ms
patient
although
particular
extent
humor
immun
respons
appear
stabl
time
ms
patient
vari
significantli
interindividu
togeth
high
variabl
clinic
phenotyp
diseas
progress
tempt
specul
whether
differ
pathogenet
pathway
even
etiolog
underli
histolog
defin
subtyp
ms
howev
character
inflammatori
also
neurodegen
chang
alreadi
promin
earli
cours
diseas
acut
lesion
extent
axon
damag
correl
inflamm
especi
invas
macrophag
cell
suggest
cell
popul
directli
involv
caus
axon
loss
much
less
known
immunopatholog
chronic
activ
silent
lesion
chronic
activ
lesion
featur
ongo
inflamm
demyelin
axon
degener
although
inflamm
usual
less
vigor
acut
lesion
gliosi
perman
neuron
oligodendrogli
damag
variabl
degre
demyelin
occur
silent
lesion
littl
cellular
infiltr
activ
immun
mediat
role
immun
system
pathogenesi
ms
first
suggest
observ
acut
demyelin
episod
follow
rabi
vaccin
vaccin
contamin
myelin
antigen
rais
possibl
diseas
induc
antimyelin
immun
respons
hypothesi
confirm
anim
model
immun
myelin
antigen
freund
adjuv
give
rise
cn
inflamm
suscept
anim
anim
model
term
experiment
autoimmun
encephalomyel
eae
target
antigen
extent
demyelin
presenc
degre
inflamm
diseas
cours
depend
anim
strain
genet
background
role
autoimmun
respons
model
confirm
adopt
transfer
experi
demonstr
predominantli
cell
diseas
anim
transmit
diseas
naiv
anim
cell
secret
thelper
th
cytokin
eg
interferon
tumor
necrosi
factor
interleukin
il
proinflammatori
cytokin
potent
transfer
diseas
myelinspecif
cell
cell
secret
cytokin
convers
seem
protect
amelior
eae
although
cell
diseasetransf
popul
reli
innat
immun
cn
microglia
cell
provid
proinflammatori
milieu
requir
effici
tcell
recognit
autoantigen
togeth
find
establish
eae
prototyp
autoimmun
disord
creat
wide
accept
paradigm
tcell
respons
myelin
antigen
destruct
wherea
respons
protect
base
observ
administr
cytokin
exacerb
ms
eae
concept
extrapol
human
diseas
fig
foster
numer
effort
character
immun
respons
myelin
antigen
ms
patient
antibodi
myelin
antigen
detect
serum
csf
cn
ms
patient
similarli
cell
specif
varieti
myelin
antigen
present
blood
ms
patient
recent
studi
demonstr
cell
recogn
respond
larg
number
differ
antigen
among
varieti
self
foreign
antigen
includ
peptid
deriv
microb
howev
abil
react
larg
number
differ
antigen
confin
autoreact
cell
probabl
intrins
featur
cell
recognit
nevertheless
high
degeneraci
tcell
recognit
observ
provid
possibl
explan
autoreact
cell
may
activ
exogen
infecti
agent
initi
first
demyelin
episod
molecular
mimicri
first
destruct
event
myelin
antigen
releas
may
prime
chronic
polyreact
autoimmun
process
epitop
spread
although
autoimmun
hypothesi
gener
eae
model
involv
molecular
mimicri
epitop
spread
attract
explain
mani
aspect
ms
experiment
support
hypothesi
still
limit
likewis
cell
specif
myelin
antigen
retriev
ms
patient
also
healthi
donor
indic
autoreact
cell
part
normal
tcell
repertoir
necessarili
harm
far
studi
provid
conclus
result
myelinspecif
cell
differ
term
antigen
recognit
phenotyp
ms
patient
control
subject
similarli
myelinspecif
antibodi
confin
ms
detect
differ
neurolog
diseas
even
healthi
control
subject
past
decad
mani
experiment
immunotherapi
ms
base
eae
model
intervent
strategi
includ
global
immunosuppress
inhibit
proinflammatori
cytokin
shift
immun
respons
howev
studi
eae
model
quickli
rais
question
whether
concept
appli
without
modif
eae
model
importantli
human
diseas
first
object
came
studi
genet
modifi
anim
experiment
set
anim
lack
develop
similar
even
sever
eae
wildtyp
litterm
contrast
disrupt
gene
affect
diseas
cours
transgen
mous
model
even
possibl
induc
eae
myelinspecif
cell
final
therapeut
approach
base
myelin
peptid
induc
shift
unexpectedli
result
sever
relaps
eae
monkey
model
varianc
classic
eae
dogma
myelinspecif
cell
may
even
evok
eae
certain
condit
model
lesion
restrict
brain
character
extens
demyelin
cell
death
although
eae
adopt
transfer
b
cell
antibodi
also
undoubtedli
import
diseas
cours
model
eae
sever
significantli
enhanc
coadministr
myelinspecif
antibodi
induct
diseas
clinic
trial
ms
patient
strengthen
view
eae
concept
simpli
appli
human
diseas
treatment
ms
patient
block
antibodi
solubl
tnf
receptor
precipit
acut
attack
global
deplet
cell
impact
diseas
cours
ms
antigenbas
therapi
toler
induct
oral
applic
myelin
applic
alter
peptid
deriv
myelin
antigen
ineffici
even
worsen
diseas
mani
immunmodulatori
immunosuppress
drug
fail
clinic
trial
date
three
drug
approv
treatment
rrm
spm
novantron
cytotox
drug
immunosuppress
properti
seem
reduc
relaps
rate
progress
ms
glatiram
acet
randomli
synthes
polypeptid
mixtur
base
four
amino
acid
contain
high
level
myelin
protein
also
seem
decreas
relaps
rate
among
postul
therapeut
effect
immunomodulatori
neuroprotect
properti
far
robust
data
avail
strongli
suppress
mri
activ
decreas
relaps
rate
also
seem
affect
diseas
progress
drug
exhibit
antivir
immunomodulatori
effect
although
mode
action
ms
still
entir
understood
given
inconclus
result
role
antimyelin
respons
ms
disappoint
outcom
number
clinic
trial
rethink
pathogenet
scenario
accumul
inflamm
demyelin
destruct
cn
tissu
need
inflamm
demyelin
observ
autoimmun
condit
also
follow
infect
even
primari
neurodegen
event
fig
idea
ms
caus
neurotrop
agent
sup
port
identif
caus
virus
subacut
scleros
panenceph
sspe
human
tcell
leukemia
virusi
htlvi
associ
myelopathi
mammal
varieti
virus
elicit
acut
chronic
cn
demyelin
inflamm
eg
theiler
murin
encephalomyel
viru
mous
hepat
viru
model
predominantli
also
cell
crucial
control
viru
acut
phase
wherea
b
cell
antibodi
seem
relev
chronic
diseas
phase
although
tcell
bcell
respons
clearli
import
contain
infect
may
also
contribut
tissu
damag
possibl
neg
impact
immun
system
activ
primari
infecti
cn
disord
particularli
impress
experiment
borna
viru
diseas
untreat
anim
may
develop
sever
immunemedi
encephalomyel
wherea
toler
immunosuppress
anim
may
develop
subtl
behavior
abnorm
mani
featur
ms
compat
chronic
cn
infect
search
infecti
agent
utterli
unsuccess
although
mani
microb
associ
diseas
evid
lack
play
definit
role
pathogenesi
ms
pathogen
still
subject
intens
investig
chlamydia
pneumonia
differ
herp
virus
inflamm
howev
also
seen
acut
neurodegen
disord
traumat
cn
tissu
damag
stroke
loss
cn
tissu
integr
associ
microglia
activ
cytokin
product
infiltr
leukocyt
role
immun
system
disord
highli
variabl
peripher
leukocyt
deplet
inhibit
leukocyt
migrat
reduc
tissu
damag
stroke
contrast
induct
myelinspecif
immun
respons
prevent
neurodegener
model
axotomi
model
acut
neurodegener
howev
usual
result
sustain
cn
inflamm
although
earli
loss
neuron
oligodendrocyt
compat
primari
neurodegen
process
extent
inflamm
ms
explain
involv
addit
immunolog
factor
diseas
pathogenesi
possibl
mechan
heighten
immunoreact
autoantigen
defect
control
immun
respons
cn
concept
involv
cn
infect
primari
neurodegener
provid
import
insight
mechan
neuroinflamm
clarifi
etiolog
ms
therefor
recent
effort
focus
immunolog
neurodegen
chang
cn
ms
patient
shed
light
natur
local
immun
respons
emerg
novel
techniqu
seem
possibl
dissect
molecular
mechan
within
cn
find
new
clue
diseas
pathogenesi
one
first
immunolog
observ
ms
find
high
immunoglobulin
g
igg
level
csf
appar
caus
local
oligoclon
igg
respons
mainli
entail
isotyp
igg
respons
involv
limit
number
clonotyp
respons
oligoclon
igg
band
pattern
csf
inde
occurr
oligoclon
intrathec
antibodi
respons
still
reliabl
immunolog
test
diagnosi
ms
although
specif
similarli
found
varieti
predomin
infecti
diseas
cn
eg
sspe
neurosyphili
neuroborreliosi
disord
antibodi
compris
oligoclon
band
recogn
antigen
infecti
agent
pattern
intrathec
antibodi
product
ms
chang
significantli
cours
diseas
suggest
antibodi
secret
long
period
time
find
recent
complement
b
cell
repertoir
analys
csf
cn
ms
patient
studi
demonstr
preferenti
use
specif
heavi
chain
gene
clonotyp
accumul
b
cell
local
compart
b
cell
cn
lesion
display
extens
replac
mutat
cluster
hypervari
region
bcell
receptor
bcr
gene
compar
bcr
matur
seen
repeat
exposur
memori
b
cell
antigen
similar
find
obtain
concern
tcell
respons
cn
ms
patient
analyz
singl
cell
cn
lesion
csf
ms
patient
two
group
demonstr
clonal
accumul
cell
local
compart
clonal
expans
predominantli
much
lesser
extent
tcell
popul
note
lesion
one
patient
cell
deriv
singl
cell
evidenc
analysi
molecular
structur
rearrang
tcell
receptor
cell
identifi
low
number
blood
patient
suggest
specif
migrat
accumul
cn
compart
two
main
find
character
recent
advanc
understand
ms
immunolog
ms
heterogen
diseas
respect
clinic
phenotyp
patholog
chang
inherit
level
complex
contrast
highli
focus
local
immun
respons
brain
ms
patient
signific
number
cell
lesion
origin
singl
cell
similarli
b
cell
clonotyp
accumul
brain
ms
patient
bcr
antigen
matur
although
primari
event
drive
immun
respons
cn
still
unknown
highli
like
initi
perpetu
take
place
lymphoid
tissu
antigen
releas
cn
compart
process
present
antigenpres
cell
dendrit
cell
dc
probabl
play
key
role
process
prime
cell
similarli
b
cell
respons
initi
solubl
antigen
enter
spleen
lymph
node
specif
recognit
antigen
result
clonal
expans
b
cell
acquisit
effector
function
cell
circul
bodi
enter
cn
mechan
transendotheli
migrat
mediat
complex
interplay
cellular
adhes
molecul
chemokin
matrix
metalloproteinas
within
cn
encount
target
antigen
present
cn
cell
cell
respond
antigen
present
hlaclass
iexpress
cn
cell
among
neuron
glia
cell
upon
recognit
specif
hla
peptid
complex
cell
may
releas
cytokin
directli
damag
antigen
present
cell
vitro
cell
lyse
neuron
oligodendrocyt
fig
induc
neurit
damag
antigendepend
fashion
given
broad
express
hlaclass
molecul
brain
accumul
cell
extent
axon
loss
demyelin
acut
lesion
like
cell
play
central
role
inflammatori
process
cn
ms
patient
cell
requir
present
antigen
context
hlaclass
ii
molecul
major
sourc
endogen
hlaclass
ii
express
cn
activ
microglia
cell
upon
reactiv
cell
initi
effector
function
synthes
cytokin
chemokin
releas
proinflammatori
molecul
recruit
inflammatori
cell
macrophag
lesion
fig
although
cell
play
central
role
eae
function
ms
less
clear
cell
predominantli
found
mening
seem
clonal
origin
find
exclud
central
role
cell
ms
capac
cell
expand
clonal
much
higher
counterpart
cell
could
still
target
defin
diseaseassoci
antigen
much
broader
fashion
hand
cell
brain
ms
patient
capac
releas
neurotrop
factor
brainderiv
neurotroph
factor
bdnf
thu
tempt
specul
cell
import
neuroregener
protect
observ
axotomi
model
final
humor
immun
respons
also
seem
play
essenti
role
diseas
pathogenesi
view
support
occurr
persist
intrathec
igg
respons
clonal
accumul
b
cell
cn
ms
patient
contrast
cell
antibodi
depend
present
hla
express
recogn
solubl
bound
protein
antibodi
bind
cell
surfac
activ
complement
cascad
could
thu
directli
damag
antigenexpress
cell
fig
howev
similar
cell
antibodi
may
mediat
detriment
effect
also
promot
regener
accord
anim
studi
humor
immun
respons
seem
import
chronic
phase
diseas
sever
studi
investig
target
local
humor
immun
respons
ms
use
express
phage
display
librari
antigen
mimic
identifi
although
yet
pathogenet
role
ms
establish
besid
acquir
immun
respons
macrophag
microglia
also
seem
essenti
demyelin
axon
loss
fig
context
activ
ongo
demyelin
number
toxic
molecul
may
gener
inflammatori
cascad
glutam
nitric
oxid
matrix
metalloproteinas
calpain
forth
vigor
inflammatori
respons
may
therebi
antigennonspecif
inflict
damag
axon
wide
assum
final
common
pathway
calcium
overflow
facilit
upregul
ntype
calcium
channel
consequ
calpain
activ
eventu
cytoskeleton
disintegr
final
loss
neurotroph
support
may
compromis
axon
neuron
surviv
immun
respons
cn
ms
patient
inflammatori
phase
diseas
appear
highli
focus
involv
cell
b
cell
occurr
conserv
persist
intrathec
antibodi
secret
consist
ongo
immun
respons
protein
domin
cell
respons
argu
least
part
target
antigen
deriv
endogen
protein
synthes
within
cn
cell
given
recent
broaden
eae
concept
demonstr
encephalitogen
cell
self
antigen
antigen
neurotrop
pathogen
possibl
candid
target
antigen
ms
focu
immun
respons
cn
limit
number
autoantigen
exclus
express
cn
occur
uniqu
modif
cn
eg
splicevari
altern
protein
could
deriv
intracellular
pathogen
pathogen
must
enter
cn
persist
without
associ
lifethreaten
diseas
given
worldwid
distribut
ms
fact
signific
epidem
occur
area
ms
endem
pathogen
must
ubiquit
present
current
candid
pathogen
fulfil
requir
point
remain
uncertain
account
heterogen
clinic
phenotyp
patholog
theoret
two
scenario
possibl
case
ms
caus
one
defin
pathogenautoantigen
heterogen
like
result
individu
genet
mixup
govern
extent
phenotyp
immun
respons
vulner
differ
cn
cell
well
neuroprotect
neuroregener
altern
caus
pathogenautoantigen
may
vari
individu
patient
thu
main
drive
forc
variabl
clinic
phenotyp
patholog
key
player
immunopatholog
ms
defin
recent
studi
suggest
b
cell
cell
clonal
accumul
lesion
driven
defin
protein
antigen
independ
whether
respons
caus
protect
one
main
goal
next
year
defin
antigen
attract
acquir
immun
respons
cn
techniqu
avail
allow
determin
ligand
antibodi
cell
approach
essenti
identifi
isol
relev
antibodi
cell
organ
compart
success
approach
identifi
target
antigen
larg
depend
tool
incorpor
possibl
ligand
natur
occur
modif
studi
supplement
use
new
highthroughput
techniqu
allow
dissect
ms
lesion
order
determin
express
profil
figur
cascad
event
possibl
underli
demyelin
axon
degener
multipl
sclerosi
within
central
nervou
system
activ
lymphocyt
releas
inflammatori
cytokin
chemokin
matrix
metalloproteinas
mmp
moreov
cell
activ
microglia
cellsmacrophag
enhanc
phagocyt
activ
product
cytokin
releas
toxic
mediat
nitric
oxid
propag
demyelin
axon
loss
autoantibodi
ab
cross
bloodbrain
barrier
local
produc
b
cell
mast
cell
contribut
process
autoantigen
activ
complement
cascad
result
format
membraneattack
complex
subsequ
lysi
target
structur
cell
capabl
attack
axon
oligodendrocyt
directli
combin
toxic
signal
disturb
axonglia
interact
pave
way
axon
degener
upregul
ca
channel
increas
ca
influx
might
perpetu
process
highfrequ
signal
neuron
result
axon
degener
especi
upon
exposur
nitric
oxid
loss
signal
activ
trophic
support
might
contribut
axon
degener
connect
neuron
well
necrosi
factor
gene
protein
success
approach
larg
part
depend
qualiti
sampl
rigor
use
appropri
control
determin
express
pattern
uniqu
ms
relat
cn
inflamm
although
begin
studi
refocus
research
human
diseas
initi
event
lead
manifest
ms
may
final
provid
new
insight
etiolog
pathogenesi
ms
may
chanc
design
employ
therapi
significantli
impact
cours
disabl
diseas
